Advisory Research’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Advisory Research’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,474	Closed	-$1.02M	–	367
2020 Q3	$1.02M	Buy	7,474 +171	+2%	+$18.2K	0.1%	174
2020 Q2	$706K	Sell	7,303 -2,137	-23%	-$178K	0.06%	206
2020 Q1	$443K	Buy	+9,440	New	+$605K	0.03%	206
2019 Q1	–	Sell	-8,753	Closed	-$428K	–	394
2018 Q4	$428K	Sell	8,753 -17,942	-67%	-$988K	0.01%	312
2018 Q3	$1.74M	Buy	+26,695	New	+$1.57M	0.03%	209

Advisory Research's MYOK Position: Q4 2020 in Review

Advisory Research sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 7,474 shares — an estimated $1.02M sold.

Advisory Research first reported a position in MYOK in Q3 2018 and held it in 5 quarters. The position peaked at $1.74M in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Advisory Research reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Advisory Research sold 7,474 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.02M.
Advisory Research first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Advisory Research's MyoKardia, Inc. Common Stock position peaked at $1.74M in Q3 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.